AIGEN INVESTMENT MANAGEMENT, LP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,366,436
+258.4%
53,988
+356.1%
0.20%
+288.5%
Q1 2023$381,302
-43.0%
11,838
-67.3%
0.05%
-45.3%
Q4 2022$669,175
+187.2%
36,250
+360.8%
0.10%
+131.7%
Q2 2021$233,000
-64.6%
7,866
-70.0%
0.04%
-51.2%
Q3 2020$659,000
+137.9%
26,199
+130.6%
0.08%
+133.3%
Q2 2020$277,000
+136.8%
11,360
+43.5%
0.04%
+125.0%
Q1 2020$117,000
-22.0%
7,918
-14.1%
0.02%
-36.0%
Q4 2019$150,0009,2130.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders